South Africa's stance on nevirapine on trial.
作者信息
Baleta A
出版信息
Lancet. 2001 Nov 3;358(9292):1521. doi: 10.1016/s0140-6736(01)06626-0.
Abstract
摘要
相似文献
1
South Africa's stance on nevirapine on trial.
Lancet. 2001 Nov 3;358(9292):1521. doi: 10.1016/s0140-6736(01)06626-0.
2
South Africa shifts position on antiretroviral drugs.
Lancet Infect Dis. 2002 Jun;2(6):318. doi: 10.1016/s1473-3099(02)00299-2.
3
South African government procrastinates over policy on HIV drug.
Lancet. 2002 Feb 9;359(9305):504. doi: 10.1016/S0140-6736(02)07707-3.
4
South African court again tells government to increase access to AIDS drug.
Lancet. 2002 Mar 30;359(9312):1132. doi: 10.1016/S0140-6736(02)08188-6.
5
A grave delay for South Africa's mothers and infants.
Lancet. 2008 Feb 2;371(9610):360. doi: 10.1016/S0140-6736(08)60176-2.
6
South African government threatens to ban nevirapine. Move would take away option for treating vertical HIV transmission.
Lancet. 2003 Aug 9;362(9382):451. doi: 10.1016/s0140-6736(03)14100-1.
7
Confusion over Mandela's "support" of ANC HIV policy.
Lancet. 2002 Mar 9;359(9309):855. doi: 10.1016/S0140-6736(02)07977-1.
8
The right to health and the nevirapine case in South Africa.
N Engl J Med. 2003 Feb 20;348(8):750-4. doi: 10.1056/NEJMlim022737.
9
Nevirapine all set to succeed in Gauteng.
S Afr Med J. 2002 Dec;92(12):932-3.
10
S Africa state offers HIV drug to pregnant women.
Lancet. 2002 Feb 2;359(9304):416. doi: 10.1016/S0140-6736(02)07638-9.
Zotero 插件